Seizures can precede cognitive symptoms in late-onset Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 27, Issue 4, 2011, Pages 737-742

  Picco, Agnese ^a   Archetti, Silvana ^b   Ferrara, Michela ^a   Arnaldi, Dario ^a   Piccini, Alessandra ^a   Serrati, Carlo ^c   Di Lorenzo, Diego ^b   Morbelli, Silvia ^d   Nobili, Flavio ^a,e  

^a UNIVERSITY OF GENOA   (Italy)

^b SPEDALI CIVILI   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

^e CNR   (Italy)

Author keywords

Alzheimer's disease; amyloid protein precursor; biological markers; presenilins; seizures

Indexed keywords

AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; ETIRACETAM; FLUORODEOXYGLUCOSE F 18; PRESENILIN 1; TAU PROTEIN;

ADRENAL CORTEX ATROPHY; AGED; ALZHEIMER DISEASE; AMNESIA; AMYLOIDOSIS; ARTICLE; CASE REPORT; CAUCASIAN; CEREBROSPINAL FLUID EXAMINATION; COGNITION; DAILY LIFE ACTIVITY; DEPTH PERCEPTION; ELECTROENCEPHALOGRAM; ELECTROENCEPHALOGRAPHY; FEMALE; FOLLOW UP; GENE MUTATION; HUMAN; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; NERVE DEGENERATION; NERVE EXCITABILITY; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEIZURE; SPATIAL MEMORY; UNCONSCIOUSNESS;

EID: 84455170765     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2011-110896     Document Type: Article

References (30)

1. Lozsadi DA, Larner AJ (2006) Prevalence and causes of seizures at the time of diagnosis of probable Alzheimers disease. Dement Geriatr Cogn Disord 22, 121-124 (Pubitemid 44253207)
2. Larner AJ (2010) Epileptic seizures inADpatients. Neuromol Med 12, 71-77
3. Palop JJ, Chin J, Roberson ED, Wang J, Thwin MT, Bien-Ly N, Yoo J, Ho KO, Yu GQ, Kreitzer A, Finkbeiner S, Noebels JL, Mucke L (2007) Aberrant excitatory neuronal activity and compensatory remodelling of inhibitory hippocampal circuits in mouse models of Alzheimers disease. Neuron 55, 697-711 (Pubitemid 47321079)
4. Palop JJ, Mucke L (2009) Epilepsy and cognitive impairments in Alzheimer disease. Arch Neurol 66, 435-440
5. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH (2011) The diagnosis of mild cognitive impairment due to Alzheimers disease: Recommendations from the National Institute on Aging-Alzheimers Association workgroups on diagnostic guidelines for Alzheimers disease. Alzheimers Dement 7, 270-279
6. Dubois B, Feldman HH, Jacova C, Cummings JL, Dekosky ST, Barberger-Gateau P, Delacourte A, Frisoni G, Fox NC, Galasko D, Gauthier S, Hampel H, Jicha GA, Meguro K, OBrien J, Pasquier F, Robert P, Rossor M, Salloway S, Sarazin M, de Souza LC, Stern Y, Visser PJ, Scheltens P (2010) Revising the definition of Alzheimers disease: A new lexicon. Lancet Neurol 9, 1118-1127
7. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR Jr, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M, Wagster MV, Phelps CH (2011) Toward defining the preclinical stages of Alzheimers disease: Recommendations from the National Institute on Aging and the Alzheimers Association workgroup. Alzheimers Dementia 7, 280-292
8. Brooks WS, Kwok JB, Kril JJ, Broe GA, Blumbergs PC, Tannenberg AE, Lamont PJ, Hedges P, Schofield PR (2003) Alzheimers disease with spastic paraparesis and cotton wool plaques: Two pedigrees with PS-1 exon 9 deletions. Brain 126, 783-791 (Pubitemid 36372979)
9. Carlesimo GA, Caltagirone C, Gainotti G (1996) The Mental Deterioration Battery: normative data, diagnostic reliability and qualitative analysis of cognitive impairment. The group for the standardization of the Mental Deterioration Battery. EurNeurol 36, 378-384 (Pubitemid 26343685)
10. Barbarotto R, Laiacona M, Frosio R, Vecchio M, FarinatoA, Capitani E (1998) A normative study on visual reaction times and two Stroop colour-word tests. Ital J NeurolSci 19, 161-170
11. PetersenRC(2004) Mild cognitive impairment as a diagnostic entity. J Intern Med 256, 183-194 (Pubitemid 39222988)
12. Den Dunnen JT, Antonarakis SE (2000) Mutation nomenclature extensions and suggestions to describe complex mutations: A discussion. Hum Mutat 15, 7-12 (Pubitemid 30036162)
13. MoehlmannT,Winkler E, Xia X, Edbauer D, Murrell J, Capell A, Kaether C, Zheng H, Ghetti B, Haass C, Steiner H (2002) Presenilin-1 mutations of leucine 166 equally affect the generation of the Notch and APP intracellular domains independent of their effect on A 42 production. Proc Natl Acad Sci U S A 99, 8025-8030 (Pubitemid 34650999)
14. Edwards-Lee T, Ringman JM, Chung J, Werner J, Morgan A, St George Hyslop P, Thompson P, Dutton R, Mlikotic A, Rogaeva E, Hardy J (2005) An African-American family with early-onset Alzheimer disease and an APP (T714I) mutation. Neurology 64, 377-379
15. Larner AJ, Doran M (2006) Clinical phenotypic heterogeneity of Alzheimers disease associated with mutations of the presenilin-1 gene. J Neurol 253, 139-158 (Pubitemid 43255883)
16. Hesdorffer DC, Hauser WA, Annegers JF, Kokmen E, Rocca WA (1996) Dementia and adult-onset unprovoked seizures. Neurology 46, 727-730 (Pubitemid 26099639)
17. Thinakaran G, Borchelt DR, Lee MK, Slunt HH, Spitzer L, Kim G, Ratovitsky T, Davenport F, Nordstedt C, Seeger M, Hardy J, Levey AI, Gandy SE, Jenkins NA, Copeland NG, Price DL, Sisodia SS (1996) Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron 17, 181-190 (Pubitemid 26251602)
18. Cumbo E, Ligori LD (2010) Levetiracetam, lamotrigine, and phenobarbital in patients with epileptic seizures and Alzheimers disease. Epilepsy Behav 17, 461-466
19. Minkeviciene R, Rheims S, Dobszay MB, Zilberter M, Hartikainen J, Fülöp L, Penke B, ZilberterY, Harkany T, Pitkänen A, Tanila H (2009) Amyloid beta-induced neuronal hyperexcitability triggers progressive epilepsy. J Neurosci 29, 3453-3462
20. Palop JJ, Mucke L (2010) Amyloid-beta-induced neuronal dysfunction in Alzheimers disease: From synapses toward neural networks. Nat Neurosci 13, 812-818
21. Palop JJ, Mucke L, Roberson ED (2011) Quantifying biomarkers of cognitive dysfunction and neuronal network hyperexcitability in mouse models of Alzheimers disease: Depletion of calcium-dependent proteins and inhibitory hippocampal remodeling. Methods Mol Biol 670, 245-262
22. Mendez MF, Lim GTH (2003) Seizures in elderly patients with dementia. Epidemiology and management. Drugs Aging 20, 791-803 (Pubitemid 37159597)
23. Scarmeas N, Honig LS, Choi H, Cantero J, Brandt J, Blacker D, Albert M, Amatniek JC, Marder K, Bell K, Hauser WA, Stern Y (2009) Seizures in Alzheimer disease. Who, when, and how common. Arch Neurol 66, 992-997
24. Panza F, DIntrono A, Colacicco AM, Basile AM, Capurso C, Kehoe A, Capurso A, Solfrizzi V (2004) Vascular risk and genetics of sporadic late-onset Alzheimers disease. J Neural Transm 111, 69-89 (Pubitemid 38177819)
25. Saunders AM, Strittmatter WJ, Schmechel D, St George- Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-MacLachlam DR, Alberts MJ, Hulette C, Crain B, Goldgaber D, Roses AD (1993) Association of apoliprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimers disease. Neurology 43, 1467-1472 (Pubitemid 23230526)
26. Berlau DJ, Corrada MM, Head E, Kawas CH (2009) APOE-2 is associated with intact cognition but increased Alzheimer pathology in the oldest old. Neurology 72, 829-834
27. Lippa CF, Smith TW, Saunders AM, Hulette C, Pulaski- Salo D, Roses AD (1997) Apolipoprotein E-epsilon 2 and Alzheimers disease: Genotype influences pathologic phenotype. Neurology 48, 515-519 (Pubitemid 27087630)
28. Tiraboschi P, Hansen LA, Masliah E, Alford M, Thal LJ, Corey-Bloom J (2004) Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease. Neurology 62, 1977-1983 (Pubitemid 38738207)
29. Polvikoski T, Sulkava R, Haltia M, Kainulainen K, Vuorio A, Verkkoniemi A, Niinistö L, Halonen P, Kontula K (1995) Apolipoprotein E, dementia, and cortical deposition of betaamyloid protein. N Engl J Med 333, 1242-1247
30. Herrup K (2010) Reimagining Alzheimers disease -an agebased hypothesis. J Neurosci 30, 16755-16762